Glycobiology Microarray Platform
Glycobiology Microarray Platform
Microarray is a two-dimensional arrangement of specific biological probes (such as DNA, proteins, polysaccharides, and products or libraries of low-molecular-weight natural compounds), arranged in an addressable manner on glass slides or other substrates (such as polymer-coated glass, nitrocellulose, or plastic). It is a platform for parallel analysis of complex biological liquids in a tiny grid-like plane. Thousands of isolated biological probes with diameters ranging from 50 to 300 µm are usually arranged on the surface of the glass slide, and each spot in the array can represent a biochemical event and can be measured independently. This component allows for high-throughput multiplex analysis, usually combined with fluorescence to detect many different analytes simultaneously.
In addition to DNA and protein microarrays, there are also cell and tissue microarrays. The array combines mature cell research methods with the high-throughput screening function of microarrays, and can be used for drug screening, in vitro toxicology testing, and functional genomics research. Today, microarrays have been widely used in genome research and can be applied to various applications in the fields of biology and medicine. Microarrays accelerate the process of understanding the function of genes, proteins, and cells in living organisms. They can also be used as molecular markers for disease diagnosis, prediction, and prevention.
Fig.1 Construction of cell-based glycan arrays. (Briard, et al., 2018)
Our Services
We provide comprehensive glycobiology microarray-based assay services covering all aspects from experimental design to data analysis to meet diverse research needs.
Customized Glycobiology Microarray Design and Construction
We have a wide range of glycobiology libraries, including natural oligosaccharides, synthetic glycan chains, glycoproteins, glycolipids, and so on. Our researchers customize the design and construction of the most suitable glycobiology microarray according to the specific research objectives and biomolecular properties, with a wide range of substrates to choose from and flexible sampling.
Sample Preparation
Our glycobiology microarray platform is suitable for a wide range of biological sample types (proteins, antibodies, cells, tissues, etc.). Combined with extensive experimental experience, samples are processed and labeled upon receipt.
Hybridization and Washing
We utilize glycobiology microarrays to detect biomolecules (glycoproteins, glycolipids, lectins, antibodies, etc.) for hybridization and cleaning. State-of-the-art equipment ensures precise control and efficient execution of the entire process.
- Glycoprotein binding analysis: We utilize glycobiology microarrays to study the interactions between proteins and specific glycans. We reveal the role of glycans in protein function and discover new glycan-binding proteins.
- Antibody specificity analysis: Glycobiology microarray is used to evaluate the specific binding ability of antibodies to glycans and to validate the targeting and reliability of antibodies.
- Other types of analysis, including but not limited to transcript expression analysis.
Data Analysis
We use professional analysis software for data extraction and processing, and mine valuable biological information from complex microarray data, including but not limited to differential binding analysis, clustering analysis, and GO enrichment analysis.
Glycan Microarray Assay
Compared with traditional methods of detecting the interaction of glycans and GBP, glycan microarray has the advantages of rapidity, accuracy, and cost savings. Glycan microarrays include the following:
Glycosphingolipid Microarray
We developed microassay techniques for providing structural information on glycosphingolipid, which plays an important role in numerous biological processes.

Heparin Sulfate Microarray
We have developed heparin sulfate microarrays to help clients accelerate their scientific research. One-stop service makes clients more worry-free.
Human Milk Oligosaccharide Microarray
The microarrays we have established have accelerated progress in the study of the function and interactions of breast milk oligosaccharides.
Lectin Microarray Assay
Lectin can be used as a useful tool for studying cell recognition and adhesion. We provide a fast and high-throughput lectin microarray assay, which performs well in differential analysis.
Glyco-gene Microarray Assay
Our glyco-gene microarray assay is an advanced technology for screening and detecting changes in the transcription and expression levels of glycan-related genes.
Glycoprotein Microarray Assay
In addition to being used as biomarkers, glycoprotein microarray can also be used to screen various vaccines, so it has received widespread attention.
Glycopeptide Microarray
We have collaborated with several research teams and provided them with glycopeptide microarray services to help them screen antibodies.
Custom Microarray Printing Service
CD BioGlyco tailors the microarray printing and analysis experiments according to the client's sample type and project needs. All you need to do is to make a request.

Glycomics Profiling with Microarray
CD BioGlyco provides high-quality microarray-based glycobiological analysis solutions for our global clients.
Workflow

Advantages
- Our glycobiology microarray supports high-throughput analysis. Only a small amount of sample is needed to screen for multiple interactions simultaneously, speeding up the research process.
- Our glycobiology microarray is versatile and can be used to analyze a wide range of types, such as lectins, glycoproteins, and more.
- Our glycobiology microarrays are optimized for high sensitivity and specificity.
Applications
- These glycobiology microarrays are used to identify specific proteins that can bind to glycans to analyze the role of these glycans in various biological processes.
- These glycobiology microarrays are used to analyze the binding specificity of glycan-binding proteins, including preferred glycan structures, linkage types, and more.
- In disease studies, these glycobiology microarrays are used to understand the interactions mediated by glycans, which are essential for screening potential drug targets and related lead compounds.
Publication Data
Technology: Glycan microarray
Journal: Frontiers in Chemistry
IF: 3.693
Published: 2019
Results: Glycan microarrays are useful tools for studying glycan-glycan binding protein (GBP) interactions. This paper introduces us to strategies for the construction of glycan microarrays and their immunological applications, with a focus on the types of microarrays that contain the most comprehensive glycan structures. One strategy for constructing glycan microarrays is covalent linkage, i.e., covalent derivatization of a glycan with a specific bifunctional chemical moiety, which then covalently reacts with the functionalized solid surface. A variety of linkers have been developed to label glycans and generate microarrays. These constructed microarrays can be used to recognize endogenous immunoreceptors and other immunological applications.
Fig.2 A bifunctional fluorescent glycan junction. (Gao, et al., 2019)
Frequently Asked Questions
CD BioGlyco provides different kinds of comprehensive microarray analysis services, which not only achieve high throughput and high accuracy but also save costs and time for clients. We hope to start the exploration of glycobiology with you. If you are interested in our services, please contact us for more detailed information.
Associated Services

- GPI Anchor Pathway-based Glyco-engineered Cell Construction Service
- Glycolipids (GSL) Pathway-based Glyco-engineered Cell Construction Service
- N-linked Glycan Pathway-based Glyco-engineered Cell Construction Service
- O-GalNAc Pathway-based Glyco-engineered Cell Construction Service
- O-Fuc Pathway-based Glyco-engineered Cell Construction Service
- O-Man Pathway-based Glyco-engineered Cell Construction Service
- C-Man Pathway-based Glyco-engineered Cell Construction Service
- O-Glc Pathway-based Glyco-engineered Cell Construction Service
References
- Briard, J.G.; et al. Cell-based glycan arrays for probing glycan–glycan binding protein interactions. Nature Communications. 2018, 9(1): 880. (Open Access)
- Gao, C.; et al. Glycan microarrays as chemical tools for identifying glycan recognition by immune proteins. Frontiers in Chemistry. 2019, 7: 833. (Open Access)
Quick Links
Resources
- Glyco™ Synthesis Platform
- Custom Glycoprotein Synthesis
- Custom Glycoside Synthesis
- Custom Glycosyl Donor Synthesis
- Custom Thioglycoside Synthesis
- Custom Phosphatidylinositol Synthesis
- Custom Cyclodextrin Synthesis
- Custom Rhamnolipid Synthesis
- Custom Sphingolipid Synthesis
- Custom Building Block Synthesis
- Carbohydrate Manufacturing
- Synthesis Process Development and Optimization
- Custom Carbohydrate Synthesis
- Custom Glycolipid Synthesis
- Custom Glycopeptide Synthesis
- Custom Glycoconjugate Synthesis
- Custom Sugar-Nucleotide Synthesis
- Nucleoside & Nucleotide Synthesis Service
- Custom Oligonucleotide Synthesis Service
- Polynucleotide Synthesis Service
- Nucleoside & Nucleotide Modification Service
- Oligonucleotide Modification Service
- Nucleoside-based Production Service
- Nucleotide-based Production Service
- OPME-based NDP-sugar Synthesis Service
- OPME-based NMP-sugar Synthesis Service
- Glycomics Platform
- Glycoproteomics Platform
- N-Glycoproteomics of PDX Models
- Nanotechnologies for the Detection of Glycopeptides
- Glycoprotein Enrichment
- Glycoprotein Quantification
- Glyco-biomarker Detection Service
- Glyco-biomarker AFP Detection Service
- Glyco-biomarker CA19-9 Detection Service
- Glyco-biomarker CA125 Detection Service
- Glyco-biomarker CA15–3 Detection Service
- Glyco-biomarker CEA Detection Service
- Glyco-biomarker PSA Detection Service
- Glyco-biomarker Immunoglobulin G (IgG) Detection Service
- Glyco-biomarker Haptoglobin (Hp) Detection Service
- Glyco-biomarker α1-Antitrypsin (A1AT) Detection Service
- Glyco-biomarker α1-Acid Glycoprotein (AGP) Detection Service
- Glyco-biomarker Ceruloplasmin (CP) Detection Service
- Glyco-biomarker Fetuin A Detection Service
- Site Occupation
- Glycoprotein Structure Analysis
- Glycosylation Site-specific Antibody-Drug Conjugate (ADC) Development Platform
- Carbohydrate-based Glycomedicine Development Platform
- By Sources of Carbohydrate
- By Types of Carbohydrate
- Monosaccharides-based Glycomedicine Development
- Disaccharides-based Glycomedicine Development
- Trisaccharides-based Glycomedicine Development
- Oligosaccharides-based Glycomedicine Development
- Polysaccharides-based Glycomedicine Development
- Glycosides-based Glycomedicine Development
- Glycopeptide-based Glycomedicine Development
- Glycomimetic-based Glycomedicine Development
- By Applications of-based Glycomedicines
- Carbohydrate-based Anticoagulant Glycomedicine Development
- Carbohydrate-based Cardiovascular Glycomedicine Development
- Carbohydrate-based Antitumor Glycomedicine Development
- Carbohydrate-based Antidiabetic Glycomedicine Development
- Carbohydrate-based Antibacterial Glycomedicine Development
- Carbohydrate-based Antiviral Glycomedicines Development
- Carbohydrate-based Antiparasiti Glycomedicine Development
- By Discovery Strategies
- Glycoengineering-based Glycomedicine Development
- Production of Food Ingredients
- Multi-omics Platform for Cancer Glucose Metabolism (MOPCGM)
- Cancer Cell Glycolytic Analysis
- Cancer Cell TCA Cycle Analysis
- Cancer Cell PPP Analysis
- Gene-level Regulation Analysis of Cancer Glucose Metabolism
- Interplay Between Glucose Metabolism Reprogramming and Tumorigenesis & Progression
- Interplay Between Glucose Metabolism Reprogramming and Proliferative Signaling
- Interplay Between Glucose Metabolism Reprogramming and Growth Suppressor
- Interplay Between Glucose Metabolism Reprogramming and Cancer Cell Death
- Interplay Between Glucose Metabolism Reprogramming and Replicative Immortality
- Interplay Between Glucose Metabolism Reprogramming and Angiogenesis
- Interplay Between Glucose Metabolism Reprogramming and Invasion & Metastasis
- Interplay Between Glucose Metabolism Reprogramming and Immune Escape
- Interplay Between Glucose Metabolism Reprogramming and Genomic Instability
- Interplay Between Glucose Metabolism Reprogramming and Tumor-associated Inflammation
- Glucose Metabolism-Microenvironment Crosstalk Analysis in Cancer
- Cancer Glucose Metabolism In Vivo Analysis
- Applications of Studing Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism Small Molecule Inhibitor
- Discovery of Cancer Glucose Metabolism Therapeutic Monoclonal Antibodies
- Development of Gene Therapy Targeting Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism CAR-T Therapy Targeting
- Discovery of Cancer Glucose Metabolism Combination Therapy Strategy
- Discovery of Cancer Glucose Metabolism Precision Therapeutic Strategies
- Glycoengineering Platform
- Therapeutic Nucleic Acid Development Platform
- Therapeutic Oligonucleotide Synthesis Service
- siRNA Synthesis
- miRNA Synthesis
- ASO Synthesis
- Aptamer Synthesis
- PMO Synthesis
- sgRNA Synthesis
- Circular RNA Synthesis
- PNA Synthesis
- Lipid-based GalNac-RNA Delivery Service
- CpG Oligonucleotide Synthesis
- Click-based GalNac-RNA Delivery Service
- AntimiR Synthesis
- GalNAc-siRNA Delivery Service
- tRNA Synthesis
- GalNAc-ASO Delivery Service
- saRNA Synthesis
- Reporter Gene mRNA Synthesis
- Gene Editing mRNA Synthesis
- Gene Replacement mRNA Synthesis
- Cre Recombinase mRNA Synthesis
- hEPO mRNA Synthesis
- OVA mRNA Synthesis
- Therapeutic Oligonucleotide Modification Service
- Therapeutic Oligonucleotide Delivery Development Service
- Targeted Ligand and Linker Synthesis
- Monoantennary GalNac-RNA Delivery
- Biantennary GalNac-RNA Delivery
- Triantennary GalNac-RNA Delivery
- Tetra-antennary GalNac-RNA Delivery
- Solution Phase-based GalNac-RNA Delivery
- Solid Phase-based GalNac-RNA Delivery
- mRNA Poly(A) Tail Length Analysis
- GalNAc-siRNA Delivery
- GalNAc-ASO Delivery
- GalNAc-miRNA Delivery
- GalNAc-Aptamer Delivery
- GalNAc-AntimiR Delivery
- GalNAc-mRNA Delivery
- GalNAc-PNA Delivery
- Peptide-Therapeutic Oligonucleotide Delivery
- LNP-Therapeutic Oligonucleotide Delivery
- PEG-Therapeutic Oligonucleotide Delivery
- Biological Evaluation Service for Therapeutic Oligonucleotide
- mRNA-based Vaccine Development Service
- mRNA Sequence Design&Optimization Service
- mRNA Integrity Analysis ServicemRNA Integrity Analysis Service
- mRNA Biodistribution Analysis Service
- DNA Template Preparation Service
- mRNA Purity Analysis Service
- T Cell Cytokine Secretion Analysis Service
- mRNA Modification Service
- mRNA Length Analysis Service
- mRNA Purification Service
- Neutralizing Antibody Assay Service
- mRNA-LNP Formulation and Encapsulation Service
- mRNA Structural Characterization
- mRNA Structural Characterization Service
- mRNA Bioanalysis Service
- mRNA Residual DNA Template Analysis Service
- mRNA Residual Double-Stranded RNA (dsRNA) Analysis Service
- mRNA Size Analysis Service
- mRNA Polydispersity Analysis Service
- mRNA Zeta Potential Analysis Service
- mRNA Lipid Composition Analysis Service
- Oligonucleotide Drug Process and Formulation Development Service
- RNA Drug Process and Formulation Development
- Therapeutic Oligonucleotide Synthesis Service
- Glycobiology Microarray Platform
- Glyco™ Vaccine Development Platform
- Carbohydrate-based Vaccine Development
- Polysaccharide Vaccine Development
- Tumor-Associated Carbohydrate Vaccine Development
- Glycoconjugate Vaccine Development
- Natural Carbohydrate-based Vaccine Development
- Semi-synthetic Carbohydrate-based Vaccine Development
- Fully Synthetic Carbohydrate-based Vaccine Development
- Carbohydrate-based Antibacterial Vaccine Development
- Carbohydrate-based Antifungal Vaccine Development
- Carbohydrate-based Antiparasitic Vaccine Development
- Carbohydrate-based Antiviral Vaccine Development
- Carbohydrate-based Anticancer Vaccine Development
- Carbohydrate-based Antihelmintic Vaccine Development
- Monovalent Carbohydrate-based Vaccine Development
- Polyvalent Carbohydrate-based Vaccine Development
- Carrier Protein Design Service
- Carbohydrate Conjugation Service for Vaccine Development
- Carbohydrate-based Adjuvant Development
- Lipopolysaccharide-based Adjuvant Development
- Bacterial Outer Membrane Vesicles (OMVs)-based Adjuvant Development
- Trehalose Glycolipid-based Adjuvant Development
- Galactosylceramide-based Adjuvant Development
- Peptidoglycan-based Adjuvant Development
- Chitin/Chitosan-based Adjuvant Development
- Inulin-based Adjuvant Development
- Mannans-based Adjuvant Development
- Alginate-based Adjuvant Development
- Saponin-based Adjuvant Development
- α-Glucan-based Adjuvant Development
- Lentinan-based Adjuvant Development
- β-Glucans-based Adjuvant Development
- Deltin-based Adjuvant Development
- Muramyldipeptide-based Adjuvant Development
- Cord Factor-based Adjuvant Development
- Zwitterionic Polysaccharide-based Adjuvant Development
- Novel Plant Polysaccharides-based Adjuvant Development
- Glycoprotein-based Vaccine Development
- Glycopeptide-based Vaccine Development
- Carbohydrate-based Vaccine Development
- Glycogenomics Platform
- Glycogene Editing Service
- Glycogene Delivery Service
- Glycogene Expression Profiling
- Cancer Glycogene Discovery Service
- Glycogene Discovery Service in Cervical Cancer
- Glycogene Discovery Service in Leukemia
- Glycogene Discovery Service in Bladder Cancer
- Glycogene Discovery Service in Colorectal Adenocarcinoma
- Glycogene Discovery Service in Liver Cancer
- Glycogene Discovery Service in Lymphoma
- Glycogene Discovery Service in Breast Cancer
- Glycogene Discovery Service in Prostate Cancer
- Glycogene Discovery Service in Pancreatic Cancer
- Glycogene Discovery Service in Lung Cancer
- Glycogene Discovery Service in Thyroid Cancer
- Glycogene Discovery Service in Ovarian Cancer
- Glycan Display Platform
- Traditional Glycan Display Array
- Natural Oligosaccharide Library Construction Service
- Chemical Synthesis-based Oligosaccharide Library Construction Service
- Enzymatic Synthesis-based Oligosaccharide Library Construction Service
- Modular Synthesis-based Oligosaccharide Library Construction Service
- Oligosaccharide Library Immobilization Service
- Cell-based Glycan Display Array
- Neoglycolipid (NGL) Display Array
- Liquid Glycan Display Array (LiGA)
- Glycophage Display
- N-linked Glycoprotein-based Glycophage Display System Construction Service
- O-linked Glycoprotein-based Glycophage Display System Construction Service
- Glycophage Display-based Glycosylase Genetic Analysis Service
- Glycophag Display-based Glycoarray Service
- Glycophage Display-based Antibody Development Service
- Glycophage Display-based Epitope Mapping Service
- Glycophage Display-based Biomarker Development Service
- De Novo Glycan Display
- Cell-Surface Glycan Editing
- Examining the Effects of Altering Blood Group Antigens on Erythrocyte Cell Surfaces
- Preventing Cellular Rejection During Transplantation
- Modulating Chemical Composition and Physical Parameters of Glycocalyx
- Tailoring Cell Membranes with Biologically Active Glycans
- Targeting Glycosaminoglycan-mediated Growth Factor Signaling to Influence Stem Cell Specification
- Long-term De Novo Glycan Display for Directing Stem Cell Fate
- Traditional Glycan Display Array
- GlycoNano™ Platform
- Glyconanoparticle Development Service
- Techniques for Glyconanoparticle Development
- Carbohydrate-based Nanoparticle Production
- Gold Glyconanoparticle Production
- Silver Glyconanoparticle
- Magnetic Glyconanoparticle
- Quantum Dot (QD) Glyconanoparticle
- Glyconanoparticle Characterization
- PEG Glyconanoparticle
- Carbon-based Glyconanoparticle
- Fluorescent Glyconanoparticle
- Silica Glyconanoparticle
- Liposome Glyconanoparticle
- Glycol Nanohydrogel Development
- Glycol Nanorod
- Glycol Nanotube
- Glycol Nanocrystal/Nanosheet/Nanosphere/Nanofiber
- Glyconanoparticle Preclinical Study
- Glyconanoparticle Formulation
- Glyconanotechnology-based Biosensor Development
- GlycoNano™ Bioink Production for 3D Printing
- Glyconanoparticle Development Service
- Glyco™ Synthesis Platform




